Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

20081,243 citationsJournal Article

Authors

Partnerships for the goals

Published in: The Lancet

Volume 372, Issue 9652, pp. 1809-1818

Field-Weighted Citation Impact: 111.79